Type I interferons are associated with subclinical markers of cardiovascular disease in a cohort of systemic lupus erythematosus patients. - Wikidata - awgldk - TriplyDB

Type I interferons are associated with subclinical markers of cardiovascular disease in a cohort of systemic lupus erythematosus patients.

Type I interferons are associated with subclinical markers of cardiovascular disease in a cohort of systemic lupus erythematosus patients.

http://www.wikidata.org/entity/Q34273836

about

Unmet medical needs in systemic lupus erythematosus Cardiovascular disease in lupus: insights and updates The effect of type 1 IFN on human aortic endothelial cell function in vitro: relevance to systemic lupus erythematosus.Rheumatic autoimmune diseases in women and midlife health IFN-λ1 with Th17 axis cytokines and IFN-α define different subsets in systemic lupus erythematosus (SLE).Type I interferon in the pathogenesis of lupus.Monocyte activation from interferon-α in HIV infection increases acetylated LDL uptake and ROS production Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus Endothelial progenitor cell phenotype and function are impaired in childhood-onset systemic lupus erythematosus.Role of interferon alpha in endothelial dysfunction: insights into endothelial nitric oxide synthase-related mechanisms Type I interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosis Increased IFNα activity and differential antibody response in patients with a history of Lyme disease and persistent cognitive deficits.Cardiovascular risk in pediatric-onset rheumatological diseases.Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus Increased serum type I interferon activity in organ-specific autoimmune disorders: clinical, imaging, and serological associations.IFNα serum levels are associated with endothelial progenitor cells imbalance and disease features in rheumatoid arthritis patients Imbalance between endothelial damage and repair: a gateway to cardiovascular disease in systemic lupus erythematosus.A review of studies of the proteomes of circulating microparticles: key roles for galectin-3-binding protein-expressing microparticles in vascular diseases and systemic lupus erythematosus.Future prospects in biologic therapy for systemic lupus erythematosus.Advances in understanding the role of type I interferons in systemic lupus erythematosus.Pathogenesis and treatment of atherosclerosis in lupus.Type I IFNs as biomarkers in rheumatoid arthritis: towards disease profiling and personalized medicine.Cardiovascular risk factors, burden of disease and preventive strategies in patients with systemic lupus erythematosus: a literature review.Oxidized LDL activated eosinophil polarize macrophage phenotype from M2 to M1 through activation of CD36 scavenger receptor.Endothelial progenitor dysfunction associates with a type I interferon signature in primary antiphospholipid syndrome.Endothelial dysfunction in systemic lupus erythematosus - a case-control study and an updated meta-analysis and meta-regression.Dysfunction of endothelial progenitor cells is associated with the type I IFN pathway in patients with polymyositis and dermatomyositis.Endothelial dysfunction is associated with activation of the type I interferon system and platelets in patients with systemic lupus erythematosus.IFN-α Negatively Regulates the Expression of Endothelial Nitric Oxide Synthase and Nitric Oxide Production: Implications for Systemic Lupus Erythematosus.Unraveling Vascular Inflammation: From Immunology to Imaging.Decreased flow-mediated dilatation in patients with systemic lupus erythematosus: a meta-analysis.Heterogeneity of the Type I Interferon Signature in Rheumatoid Arthritis: A Potential Limitation for Its Use As a Clinical Biomarker.Endocan Levels and Subclinical Atherosclerosis in Patients With Systemic Lupus Erythematosus.Circulating microRNA expression profiles associated with systemic lupus erythematosus.Neutrophil subsets and their gene signature associate with vascular inflammation and coronary atherosclerosis in lupus.Report of the inaugural Interferon Research Summit: interferon in inflammatory diseases.

P2860

Q27005906-3D760EBC-9B19-4A1E-B329-24B2B51225C5 Q27016554-625919A4-C4E5-4BA7-8F6D-249F0E5DF28E Q33588015-D4CF1000-94B7-441D-AF69-7863EA59B9BF Q33727015-B1A7A57E-1C54-491D-A76B-5B4EADF19E35 Q33801351-80252965-BB0D-4873-83BF-6A41B0E73950 Q33852174-59B20AB9-657D-4E13-8862-9F025515D5E0 Q34292033-132E76D4-5AD0-4FC7-8991-30AA93B5BA3E Q34343906-8D63408E-459B-4798-8AEC-AF99D5320BC9 Q35901110-6A549A8A-B846-496E-866D-0CC19BCB989D Q35920339-D5D89CC9-7298-4955-B237-2816D08CA335 Q36139902-3D3AD671-583C-487C-B2E3-2BB0A4CD7771 Q36569278-49A61321-C2CD-4DA9-ADEB-08C80FA5D67E Q36903089-A549E9C7-3A7E-4907-B7F0-F16217FC3C52 Q36966870-F0476ECC-CAF3-4523-93C6-A5B2B03177E9 Q37103639-F5B27428-A546-4693-A108-69EB4949695C Q37500133-23454379-77AF-43B2-88A0-BB4084A9D369 Q37699812-EF0E19ED-64B4-4813-AFA3-914ED9FA9C1B Q37742466-0EC33A89-0F59-48AA-86CE-80D1F0A8CE35 Q38135706-E6FE38B6-317C-453F-A56F-7CAEDAB3F28A Q38227972-85A1279B-BDD7-48E0-9E0D-08A9B5AFD305 Q38230699-B5B56FF8-D92D-47DE-8538-28A221F3F893 Q38335622-4970AF36-2866-4FB4-B8F3-4E6B6CAE9D07 Q38554636-BB5D48E9-07D2-4731-87C7-43D8FCB28525 Q38721469-E01E8FCF-D5DA-4FCE-9186-A477DF2BA65E Q39586997-4BA59AA7-F654-4660-8FB6-D3A256874256 Q41260389-9707BE4F-71C0-4756-A83B-5B31EDCE4286 Q42726421-9DA77BE1-24C6-4151-8C76-A7AC9E45BE10 Q46061403-3AA1B2B2-EE3C-4532-8B4D-6EF1EB486830 Q47806004-9A372123-564A-460C-96FB-B305279267D1 Q47960412-7E698EA6-133F-45E2-B53E-5B3F09F1E398 Q48858141-20D6C751-5202-4D76-AD38-410858C13713 Q49539654-0760146A-7906-447D-B614-734F64D85F3B Q50907604-9C7F5036-49EA-4815-A130-347778E14D2F Q54272397-95015A73-AD88-417E-82D8-635AF60FCD9C Q55185377-8277CE01-EEA4-4947-976C-012B1631716F Q55383884-360EE50E-8B24-4C30-BB8F-9882B1A32A98

P2860

Type I interferons are associated with subclinical markers of cardiovascular disease in a cohort of systemic lupus erythematosus patients.

http://www.wikidata.org/entity/Q34273836

description

2012 nî lūn-bûn

@nan

2012 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Type I interferons are associa ...... lupus erythematosus patients.

@ast

Type I interferons are associa ...... lupus erythematosus patients.

@en

Type I interferons are associa ...... lupus erythematosus patients.

@nl

type

label

Type I interferons are associa ...... lupus erythematosus patients.

@ast

Type I interferons are associa ...... lupus erythematosus patients.

@en

Type I interferons are associa ...... lupus erythematosus patients.

@nl

prefLabel

Type I interferons are associa ...... lupus erythematosus patients.

@ast

Type I interferons are associa ...... lupus erythematosus patients.

@en

Type I interferons are associa ...... lupus erythematosus patients.

@nl

P1433

Q34273836-A4EDAC1C-3AB1-413C-8146-2B22670A3C7B

P1476

Q34273836-CC78EA42-E4CD-4747-AE13-D66CFD190C33

P2093

Q34273836-623D9FCA-4796-4A29-9E87-9FB4396C6C3B

Q34273836-6B1495E9-3FF7-4068-AE14-6D1FEE1C4AC8

Q34273836-7449DFBD-9C25-4FFF-BB3F-6AB39E8AF580

Q34273836-778A5658-7E74-4B06-AD5F-34ED98F07D27

Q34273836-7B44D419-4E54-42C6-A9B2-88436312D4BC

Q34273836-C2BD2295-70FC-4C07-BBB8-45CB0A8DBD68

Q34273836-C8D243C3-7E8A-4E1A-851C-176FC68F3F23

P2860

Q34273836-00A6E88C-4C03-435F-A532-04547B2C93DC

Q34273836-0576B00E-B5D6-4CEE-AB80-28548ECBB191

Q34273836-05D548A9-1BEB-4EC1-82ED-C366EE680674

Q34273836-0DEF9818-D109-4448-A5D9-9ED0ECB25CBC

Q34273836-0F06542C-5723-4AAA-8FAB-F2A5CF5210A0

Q34273836-176D9228-8359-44EB-A743-968246B16801

Q34273836-1B28E513-2A86-447B-9B2B-6C4E946F574B

Q34273836-1BDFBA57-B726-4EDA-B8F9-E150F5A2B110

Q34273836-2121E45B-F260-4DFD-8AE6-236170CD4327

Q34273836-2580BDB9-C188-4E73-9E87-032B624334B6

P304

Q34273836-5E5EFF0F-1105-4F60-8368-E09E8B9EC664

P31

Q34273836-2BDE32CF-84A1-4ABE-B577-0CEB1D24C63B

P356

Q34273836-CC3A8DCB-58F4-4678-BEBF-60E2DF3DACB4

P407

Q34273836-CC132167-5DAD-4E6B-A55D-92585BB87E30

P433

Q34273836-65A5FCC6-9ACA-4E30-AFAC-D799557450DD

P478

Q34273836-6F1B144F-6EF2-44AD-A219-81A9AC48D053

P50

Q34273836-3D5FE09F-8515-4629-BB86-445D0E650215

Q34273836-D6500DB1-C4FE-45E0-A709-5700796B8490

P577

Q34273836-A2EA95AD-CAF0-441E-BEDE-70248F4E9DAB

P5875

Q34273836-3C6D7C7B-2D42-4750-B08C-44FA96861A81

P698

Q34273836-8ACE4844-092A-4D78-B214-A12DDA4C1902

P921

Q34273836-285669D5-52F9-450F-83C8-CDD8ABFD1E97

P932

Q34273836-A150D602-AA02-4DFE-926E-4F6592DDEDD7

P356

JOURNAL.PONE.0037000

P1433

P1476

Type I interferons are associa ...... lupus erythematosus patients.

@en

P2093

Baskaran Sundaram

http://www.w3.org/2001/XMLSchema#string

Ella A Kazerooni

http://www.w3.org/2001/XMLSchema#string

Emily E Lewis

http://www.w3.org/2001/XMLSchema#string

Lu Wang

http://www.w3.org/2001/XMLSchema#string

Mariana J Kaplan

http://www.w3.org/2001/XMLSchema#string

W Joseph McCune

http://www.w3.org/2001/XMLSchema#string

Wenpu Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

Microarray analysis of gene expression in lupus

Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus

Circulating endothelial progenitor cells and cardiovascular outcomes

Network analysis of associations between serum interferon-α activity, autoantibodies, and clinical features in systemic lupus erythematosus

Importance of correlation between gene expression levels: application to the type I interferon signature in rheumatoid arthritis

Recruitment of women research participants: the Women's Health Registry at the University of Michigan

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

The detrimental effects of IFN-α on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefaction.

Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study.

Interferon-α increases monocyte migration via platelet-monocyte interaction in murine intestinal microvessels.

P304

e37000

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0037000

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-05-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224980290

http://www.w3.org/2001/XMLSchema#string

P698

22606325

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease

P932

3351452

http://www.w3.org/2001/XMLSchema#string